Summary
Gilead Sciences, Inc. (GILD) filed an 8-K on January 23, 2007, reporting two key events. Firstly, the company announced the appointment of Carla A. Hills to its Board of Directors, effective January 22, 2007. Ms. Hills, an experienced figure, was granted stock options and a prorated cash retainer, aligning with the company's compensation practices for non-employee directors. Secondly, the Compensation Committee approved 2006 bonuses and 2007 base salaries for named executive officers. This report details these compensation adjustments, reflecting performance-based awards for 2006 and adjusted base salaries for 2007. Notably, the target bonus for the CEO in 2007 was increased. These disclosures provide transparency into executive compensation and board composition changes.
Key Highlights
- 1Carla A. Hills appointed to Gilead's Board of Directors.
- 2Ms. Hills received stock options and a prorated cash retainer as compensation.
- 32006 bonuses and 2007 base salaries for named executive officers were approved.
- 4Bonuses were awarded based on the achievement of specified performance targets.
- 52007 base salaries for key executives have been established.
- 6The CEO's target 2007 bonus award was increased to 110% of base salary.
- 7The filing includes a press release announcing Ms. Hills' appointment as Exhibit 99.1.